Author

Mary Holmay

Observed name: Mary J. Holmay

Institution: Citizens United for Research in Epilepsy

Observed institutions: University of Minnesota, Cornell University, Citizens United for Research in Epilepsy, Upsher-Smith Laboratories (United States), Taysha Gene Therapies (United States), Greenwich Biosciences (United States)

ORCID: 0009-0005-0835-8810

Observed ORCID: 0009-0005-0835-8810

OpenAlex ID: A5058099738

N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases

2013 · Mary J. Holmay, Melissa Terpstra, et al. · Clinical Neuropharmacology · 225

Interaction of N-acetylcysteine and Cysteine in Human Plasma

2012 · Kendra K. Radtke, Lisa D. Coles, et al. · Journal of Pharmaceutical Sciences · 33

Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies

2022 · Kimberly Goodspeed, Rachel M. Bailey, et al. · Frontiers in Neurology · 11

PDF

Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes

2016 · Annie M. Clark, John M. Pellock, et al. · Epilepsy & Behavior · 11

Improving Patient-Centered Communication about Sudden Unexpected Death in Epilepsy through Computerized Clinical Decision Support

2021 · Randall W. Grout, Jeffrey Buchhalter, et al. · Applied Clinical Informatics · 9

PDF

A companion to the development of common data elements for Sudden Unexpected Death in Epilepsy (SUDEP)

2025 · Sloka S. Iyengar, Elaine K. O'Loughlin, et al. · Epilepsia Open · 6

PDF

Enhancing sudden unexpected death in epilepsy ( SUDEP ) research through development of common data elements

2025 · Sloka S. Iyengar, Elaine K. O'Loughlin, et al. · Epilepsia Open · 5

PDF

Clinical Decision Support to Promote SUDEP Discussions (P5.6-051)

2019 · Stephen Downs, Randall Grout, et al. · Neurology · 1

Pharmacology and Clinical Effects of N-acetylcysteine in Neurodegenerative Disorders

2015 · Mary Holmay · University of Minnesota Digital Conservancy (University of Minnesota) · 1

PDF

Investigations of USL255, Qudexy™ XR (Topiramate) Extended-Release Capsules, Sprinkled onto Soft Food or Delivered via Enteral Feeding Tubes (P1.248)

2015 · Mary Holmay, Annie Clark, et al. · Neurology · 1

Towards a Unified Research Agenda: International Consensus to Advance Understanding and Prevention of Sudden Unexpected Death in Epilepsy

2026 · Hannah Pickard, Elaine K. O’Loughlin, et al. · Epiliepsy currents/Epilepsy currents

Long-Term Efficacy of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules) by Refractory Status and Age: PREVAIL OLE (P2.054)

2016 · Robert Hogan, Ilan Blatt, et al. · Neurology

Development of Unique Dosage Form and Differentiating Features of USL255, Qudexy® XR (Topiramate) Extended-Release Capsules (P2.048)

2016 · Steve Chung, Robert Hogan, et al. · Neurology

Neurocognitive Adverse Event Profile of USL255 (Qudexy® XR; Topiramate Extended-Release Capsules): Phase 3 PREVAIL and PREVAIL OLE Studies (P4.222)

2016 · Ilan Blatt, Steve Chung, et al. · Neurology

Generic Antiepileptic Drugs: A Review of Issues Surrounding Formulation Switching (P4.268)

2015 · Huy Nguyen, Annie Clark, et al. · Neurology

Comparison of Adverse Effects of USL255 and Commonly Prescribed AEDs: Assessment of Relative Risk (P3.266)

2014 · Kimford Meador, Frank Gilliam, et al. · Neurology

Feasibility Study in Gaucher and Parkinson Patients to Assess Glutathione Levels in the Brain and Red Blood Cells Following Intravenous N-acetylcysteine

2012 · Mary Holmay, Lisa Coles, et al. · Molecular Genetics and Metabolism

Works count: 17

Citation count: 303

H-index: 6

I10-index: 4